Am J Gastroenterol

1. HASJIM BJ, Patel M, Chen S, Ichii H, et al
   Social Determinants of Health and Liver Transplant Outcomes in U.S. Indigenous Populations.
   Am J Gastroenterol. 2025 Sep 26. doi: 10.14309/ajg.0000000000003770.
   

   >> Share

   
   
2. ABU-RUMAILEH M, Dhoop S, Pace J, Qapaja T, et al
   Social Determinants of Health Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease Prevalence and Severity: A Systematic Review and Meta-Analysis.
   Am J Gastroenterol. 2025;120:2810-2820.
   

   >> Share

   
   

   
   Anticancer Res

3. TANIOKA N, Seo S, Kawanishi Y, Fujisawa K, et al
   Precise Anatomical Resection of the Left Lateral Section Using Extrahepatic Glissonean Approach and Fluorescence Guidance.
   Anticancer Res. 2025;45:5689-5695.
   

   >> Share

   
   
4. FURUKAWA K, Haruki K, Shirai Y, Onda S, et al
   Pulmonary Emphysema Assessed by the Goddard Score Predicts Outcomes After Hepatic Resection for Colorectal Liver Metastases.
   Anticancer Res. 2025;45:5765-5772.
   

   >> Share

   
   
5. WU J, Fu X, Chang S, Su W, et al
   Homochlorcyclizine Dihydrochloride Inhibits Hepatocellular Carcinoma Progression and Cancer Stem Cell Properties.
   Anticancer Res. 2025;45:5465-5475.
   

   >> Share

   
   
6. KUWANO A, Tanaka K, Hamamoto T, Kurosaka K, et al
   Prior Radiotherapy Improves Progression-free Survival in Patients With Advanced Hepatocellular Carcinoma Treated With Tremelimumab-Durvalumab.
   Anticancer Res. 2025;45:5697-5708.
   

   >> Share

   
   
7. HAYASHI K, Suzuki O, Ichise K, Uchida H, et al
   Carbon-ion Radiotherapy for Hepatocellular Cancer Arising in Transplanted Liver Tissue.
   Anticancer Res. 2025;45:5807-5812.
   

   >> Share

   
   

   
   Biochem Biophys Res Commun

8. LIN JC, Huang TS, Chen YB, Chen TY, et al
   Nedd4 family interacting protein 1 (NDFIP1) is a novel target of PF-429242 in promoting autophagy in hepatocellular carcinoma cells.
   Biochem Biophys Res Commun. 2025;794:153065.
   

   >> Share

   
   
9. OKURA K, Koyama Y, Nishio T, Kurata Y, et al
   Activated hepatic stellate cells are required for Hippo-YAP activation and functional liver regeneration following portal vein ligation in mice.
   Biochem Biophys Res Commun. 2025;794:153071.
   

   >> Share

   
   
10. WANG H, Yang Q, Xiang H, Yao L, et al
    Key oxidized lipid metabolites in pancreatic cancer tissue and metastasis based on metabolomics analysis.
    Biochem Biophys Res Commun. 2025;792:152900.
    

    >> Share

    
    

    
    BMC Cancer

11. BAS O, Inci BK, Eroglu I, Efil SC, et al
    Real-world evidence of ribociclib-induced hepatotoxicity in patients with breast cancer: a multi-center experience.
    BMC Cancer. 2025;25:1831.
    

    >> Share

    
    
12. QIU H, Chen K, Qiu Y, Yang Y, et al
    Preoperative prediction of microvascular invasion in Intra-hepatic cholangiocarcinoma using serum tumor markers integrated with inflammatory and liver function indices.
    BMC Cancer. 2025 Dec 2. doi: 10.1186/s12885-025-15245.
    

    >> Share

    
    
13. SU D, Zhang X, Wu Y, Sun K, et al
    Diagnostic value of Gd-EOB-DTPA enhanced MRI in hepatocellular carcinoma with hyperintensity on hepatobiliary phase with cirrhosis.
    BMC Cancer. 2025 Nov 29. doi: 10.1186/s12885-025-15365.
    

    >> Share

    
    
14. YANG Z, Qiu L, Jia G, Sun Z, et al
    Multi-omics analysis reveals the role of tumor-infiltrating CD4(+)CCR7(+) T cells in EGFR antibody resistance and prognosis of hepatocellular carcinoma.
    BMC Cancer. 2025 Nov 29. doi: 10.1186/s12885-025-15276.
    

    >> Share

    
    
15. DENG J, Wu Z, Ning S, Chang X, et al
    Curcumin induces ferroptosis in hepatocellular carcinoma by regulating the P62-KEAP1-NRF2-signaling pathway.
    BMC Cancer. 2025 Nov 29. doi: 10.1186/s12885-025-15307.
    

    >> Share

    
    

    
    BMC Gastroenterol

16. SUN J, Xu C, Liang Q, Yang N, et al
    Clinical outcomes of combined transarterial chemoembolization and microwave ablation for hepatic hemangiomas: a comparative analysis of large versus. giant tumors.
    BMC Gastroenterol. 2025 Nov 28. doi: 10.1186/s12876-025-04443.
    

    >> Share

    
    
17. CHEN J, Wang S, Xin X, Xie J, et al
    Effects of exercise interventions on metabolic and hepatic function markers in overweight or obese patients with MASLD: a systematic review and meta-analysis.
    BMC Gastroenterol. 2025 Dec 2. doi: 10.1186/s12876-025-04517.
    

    >> Share

    
    
18. ZHAO Q, Xiao J, Yin Q, Xu Y, et al
    Comprehensive nutritional management incorporating home-based dietary consultation improves hepatic encephalopathy in cirrhotic patients: a retrospective cohort study.
    BMC Gastroenterol. 2025 Dec 2. doi: 10.1186/s12876-025-04520.
    

    >> Share

    
    
19. DING S, Lu S, Cui L, Li J, et al
    Association between duration of alcohol consumption and risk of hematemesis in patients with alcoholic cirrhosis complicated by esophagogastric variceal bleeding: a case-control study.
    BMC Gastroenterol. 2025;25:849.
    

    >> Share

    
    
20. WEI Y, Huang S, Zhu C, Huang J, et al
    Endoscopic Histoacryl injection with clips is associated with lower early rebleeding compared to Histoacryl injection alone in the treatment of gastric varices.
    BMC Gastroenterol. 2025;25:850.
    

    >> Share

    
    

    
    Endoscopy

21. NAMIMA D, Kamada H, Nishiyama N, Fujita N, et al
    Virtual reality cross-sections matched to endoscopic ultrasound for preprocedural simulation of hepaticogastrostomy.
    Endoscopy. 2025;57.
    

    >> Share

    
    

    
    Gut

22. ZHOU H, Li H, Wu N, Calvisi DF, et al
    SIRT6-GLUL axis: rewiring nitrogen metabolism in intrahepatic cholangiocarcinoma.
    Gut. 2025 Dec 3:gutjnl-2025-337554. doi: 10.1136/gutjnl-2025-337554.
    

    >> Share

    
    

    
    Hepatology

23. WANG X, Zhou Y, Zhang S, Farrar C, et al
    Targeting mTORC2-Dependent AKT/FOXO1/RNF125 signaling exploits a therapeutic vulnerability in c-MET-activated and beta-catenin-mutated hepatocellular carcinoma.
    Hepatology. 2025 Dec 2. doi: 10.1097/HEP.0000000000001637.
    

    >> Share

    
    

    
    J Gastroenterol Hepatol

24. JAMES M, Smuk M, Rahman N, Black G, et al
    Epidemiology of Metabolic Dysfunction-Associated Steatotic Liver Disease in South Asian Ethnicities: A Systematic Review and Meta-Analysis.
    J Gastroenterol Hepatol. 2025;40:2830-2841.
    

    >> Share

    
    
25. ABREU ES, Fernandes GP, Lacerda HC, Reginato PH, et al
    Efficacy and Safety of Obeticholic Acid as Second-Line Therapy in Primary Biliary Cholangitis: Systematic Review and Meta-Analysis.
    J Gastroenterol Hepatol. 2025 Sep 30. doi: 10.1111/jgh.70094.
    

    >> Share

    
    
26. AL-HUNEIDI LI, Zhao F, Maas R, Ermans SJE, et al
    Liver Fat Quantification and Steatosis Grading in Fatty Liver Disease by Magnetic Resonance Imaging: Systematic Review and Meta-Analysis.
    J Gastroenterol Hepatol. 2025;40:2808-2819.
    

    >> Share

    
    
27. SATO S, Kawai H, Yamaguchi M, Nago H, et al
    Fibrosis in Asymptomatic Steatotic Liver Disease With Normal Alanine Aminotransferase: Analysis of 2448 Health Check-Up Cohort by Ultrasound Attenuation Imaging and Shear Wave Elastography.
    J Gastroenterol Hepatol. 2025;40:2987-2996.
    

    >> Share

    
    
28. SO JE, Jeong J, Hong JP, Kim DY, et al
    The Impact of Liraglutide on Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease.
    J Gastroenterol Hepatol. 2025;40:2976-2986.
    

    >> Share

    
    

    
    J Hepatol

29. MOREL-RIBEIRO P, Cornet M, Pilet J, Asif-Laidin A, et al
    Targeting ATR to overcome cisplatin resistance in hepatoblastoma.
    J Hepatol. 2025 Nov 29:S0168-8278(25)02705-9. doi: 10.1016/j.jhep.2025.
    

    >> Share

    
    

    
    Oncogene

30. ZHANG Y, Xiong C, Jiang Z, Wang X, et al
    Unveiling EMC6 as a novel pathogenic determinant in hepatocellular carcinoma: orchestration of lipid metabolism through regulation of lipid droplet-associated enzyme HSD17B13.
    Oncogene. 2025 Dec 3. doi: 10.1038/s41388-025-03649.
    

    >> Share

    
    

    
    PLoS One

31. SANGPRASERT S, Kwancharoen R, Ruamtawee W, Sethasine S, et al
    Factors influencing effective decrease of controlled attenuation parameters in metabolic-associated steatotic liver disease: A multilevel linear regression analysis at Vajira Hospital.
    PLoS One. 2025;20:e0336294.
    

    >> Share

    
    
32. XIANG H, She Z, Wang L, Peng Y, et al
    Comparison of Atezolizumab plus Aevacizumab and Atezolizumab plus Aabozantinib for advanced hepatocellular carcinoma: A cost-effectiveness analysis.
    PLoS One. 2025;20:e0337606.
    

    >> Share

    
    
33. SHU X, Xiong R, He Y, Li X, et al
    The experience of demoralization syndrome in patients with decompensated cirrhosis: A qualitative research.
    PLoS One. 2025;20:e0337182.
    

    >> Share

    
    

    
    Semin Liver Dis

34. BLANEY H, Horhat A, Saleem A, Winder GS, et al
    Integrated Alcohol Use Disorder and Liver Disease Management.
    Semin Liver Dis. 2025;45:517-530.
    

    >> Share

    
    
35. WANG TJ, Singh A
    Endohepatology in the Management of Liver Diseases.
    Semin Liver Dis. 2025;45:439-450.
    

    >> Share

    
    
36. GANGULY S, Sakane S, Hokutan K, Zhang V, et al
    Aging and Aging-Related Senescence in Liver.
    Semin Liver Dis. 2025;45:549-566.
    

    >> Share

    
    
37. SHALABY S, Ramirez-Quesada WE, Ojeda A, Perez-Campuzano V, et al
    Portosinusoidal Vascular Disorder: When to Suspect and How to Manage?
    Semin Liver Dis. 2025;45:487-497.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share